Darrell J. White

机构：Dalhousie University, Queen Elizabeth II Health Sciences Centre · ORCID：0000-0002-1341-4160

发表论文 261 篇 · 总被引 9377 次 · h-index 37

代表论文

• Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial (2024 · Nature Medicine · 被引 40)
• Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database (2023 · Blood Cancer Journal · 被引 12)
• Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma (2024 · Frontiers in Oncology · 被引 11)
• Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from the CC-92480-MM-002 Trial (2024 · Blood · 被引 9)
• Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database (2024 · Transplantation and Cellular Therapy · 被引 8)
• Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database (2024 · eJHaem · 被引 5)